Platelet-activating factor receptor.

Area of Science:

• Biochemistry and Molecular Biology
• Immunology
• Pharmacology

Background:

• Platelet-activating factor (PAF) is a potent phospholipid mediator with broad biological actions beyond platelet aggregation.
• PAF exerts its effects by binding to a specific G-protein-coupled seven transmembrane receptor, initiating intracellular signaling cascades.
• Recent advancements include elucidation of PAF receptor structure, signaling mechanisms, and genomic organization.

Purpose of the Study:

• To review the physiological and pathophysiological functions of PAF in vivo.
• To focus on the phenotypes of genetically altered mice models (PAF receptor-overexpressing and deficient).
• To summarize current knowledge on PAF and its receptor.

Main Methods:

• Identification of PAF receptor structures, signaling pathways, and genomic organization.
• Discovery of a human PAF receptor single nucleotide polymorphism (A224D) affecting cellular signaling.
• Generation and analysis of PAF receptor-overexpressing and PAF receptor-deficient mice.

Main Results:

• The human PAF receptor A224D polymorphism reduces cellular signaling without altering binding parameters.
• Genetically altered mice models provide novel in vivo approaches to study PAF functions.
• Phenotypic analysis of these mutant mice is crucial for understanding PAF's roles.

Conclusions:

• Genetically modified mouse models are essential tools for dissecting the in vivo roles of PAF.
• Understanding PAF receptor variations and their functional consequences is critical.
• Continued research on PAF and its receptor pathways will illuminate its physiological and pathophysiological significance.